Unrelated cord blood transplantation for thalassaemia: A single-institution experience of 35 patients

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 33-39

  Jaing, T H ^a   Hung, I J ^a   Yang, C P ^a   Chen, S H ^a   Chung, H T ^a   Tsay, P K ^b   Wen, Y C ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

cord blood transplantation; thalassaemia; unrelated donor

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFEROXAMINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DRB1 ANTIGEN; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ANEMIA; ARTICLE; BACTEREMIA; BETA THALASSEMIA; BRAIN HEMORRHAGE; CELL COUNT; CHELATION THERAPY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LANSKY PERFORMANCE SCORE; LUNG HEMORRHAGE; MALE; OVERALL SURVIVAL; PANCYTOPENIA; PNEUMOCYSTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SEPTICEMIA; SKIN DISEASE; SURVIVAL RATE; THROMBOCYTOPENIA; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TREATMENT OUTCOME; UNRELATED DONORS; VIRUS REACTIVATION;

ADOLESCENT; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; LYMPHOCYTE DEPLETION; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; THALASSEMIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855738192     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.39     Document Type: Article

References (29)

1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480-487. (Pubitemid 351821761)
2. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001; 79: 704-712. (Pubitemid 32776838)
3. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull World Health Organ 1995; 73: 375-386.
4. Prasad VK, Kurtzberg J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 2009; 44: 643-651.
5. Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 2006; 107: 3436-3441.
6. Wagner JE, Barker JN, DeFor TE, Barker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618. (Pubitemid 34925136)
7. Benito AI, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675-690. (Pubitemid 38499920)
8. Morris CR, Singer ST, Walters MC. Clinical hemoglobinopathies: iron, lungs and new blood. Curr Opin Hematol 2006; 13: 407-418. (Pubitemid 44607441)
9. Angelucci E, Baronciani D. Allogeneic stem cell transplantation for thalassemia major. Haematologica 2008; 93: 1780-1784.
10. Seghatchian J, Solheim BG. Current opinions on safer red cell transfusion practice and the appropriate use of alternative strategies. Transfus Apher Sci 2007; 37: 201-207. (Pubitemid 350181586)
11. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci 1995; 92: 10119-10122.
12. Cappellini MD, Piga A. Current status in iron chelation in hemoglobinopathies. Curr Mol Med 2008; 8: 663-674.
13. Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion 1997; 37: 135-140. (Pubitemid 27091897)
14. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137-2143. (Pubitemid 36302049)
15. Lucarelli G, Galimberti M, Giardini C, Polchi P, Angelucci E, Baronciani D et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci 1998; 850: 270-275. (Pubitemid 28369767)
16. Hongeng S, Pakakasama S, Chuansumrit A, Sirachainan N, Kitpoka P, Udomsubpayakul U et al. Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia. Biol Blood Marrow Transplant 2006; 12: 683-687. (Pubitemid 44226050)
17. Resnick IB, Aker M, Tsirigotis P, Shapira MY, Abdul-Hai A, Bitan M et al. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. Bone Marrow Transplant 2007; 40: 957-964. (Pubitemid 350048194)
18. Locatelli F, De Stefano P. Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia. Haematologica 2005; 90: 1592-1594. (Pubitemid 41818989)
19. Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-955.
20. Couriel D, Carpenter P, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 2006; 12: 375-396. (Pubitemid 43380955)
21. O'Brien T, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK et al. Autoimmune haemolytic anemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated transplants for non-malignant disease. Br J Haematol 2004; 127: 67-75. (Pubitemid 39331108)
22. Page KM, Mendizabal AM, Prasad VK, Martin PL, Parikh S, Wood S et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008; 14: 1108-1117.
23. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268-1273.
24. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med 2006; 57: 403-417. (Pubitemid 43261998)
25. Kurtzberg J. Update on umbilical cord blood transplantation. Curr Opin Pediatr 2009; 21: 22-29.
26. Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127: 286-297.
27. Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G. Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up. Ann N Y Acad Sci 2005; 1054: 196-205. (Pubitemid 43031025)
28. Locatelli F, Stefano PD. New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies. Br J Haematol 2004; 125: 3-11. (Pubitemid 38453271)
29. Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008; 42: 319-327.